• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的脑室液神经肽。I. 生长抑素样免疫反应性的水平与分布

Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.

作者信息

Jost S, Reuner C, Mohadjer M, Mundinger F, Cramer H

机构信息

Department of Neurology, Freiburg, W. Germany.

出版信息

Neuropeptides. 1990 Apr;15(4):219-25. doi: 10.1016/0143-4179(90)90016-r.

DOI:10.1016/0143-4179(90)90016-r
PMID:1979661
Abstract

We have measured somatostatin-like immunoreactivity SLI in cerebroventricular fluid of patients with Parkinson's disease (PD) and other extrapyramidal disorders with hyperkinesia. Patients with PD showed a significantly lower concentration of SLI when compared with levels in control patients with chronic stable multiple sclerosis or temporal lobe epilepsy. Less markedly decreased levels of SLI were also noted in patients with torsion dystonia. Of two patients with Huntington's disease one showed a high and one a medium concentration of SLI. According to the site of the stereotactic cannula, verified by ventriculopathy, SLI concentrations in CSF specimen obtained from the foramen Monro tended to be higher than in specimen from a supraforaminal level. Of 5 other patients with lateral and third ventricle being accessible during the passage of the stereotactic cannula, 4 showed higher SLI concentrations in the third ventricle compared to the lateral ventricle. High performance liquid chromatographic analysis combined with radioimmunoassay showed molecular heterogeneity of SLI in CSF. The ratio of SST-14 to SST-28 was higher in the third ventricle than in the lateral ventricle.

摘要

我们测量了帕金森病(PD)患者以及患有运动机能亢进的其他锥体外系疾病患者脑脊液中的生长抑素样免疫反应性(SLI)。与慢性稳定型多发性硬化症或颞叶癫痫的对照患者相比,PD患者的SLI浓度显著降低。扭转性肌张力障碍患者的SLI水平也有较轻微的降低。在两名亨廷顿病患者中,一名患者的SLI浓度较高,另一名患者的浓度中等。根据脑室造影证实的立体定向套管位置,从孟氏孔获取的脑脊液标本中的SLI浓度往往高于孔上水平的标本。在立体定向套管穿刺过程中可触及侧脑室和第三脑室的另外5名患者中,4名患者第三脑室的SLI浓度高于侧脑室。高效液相色谱分析结合放射免疫测定显示脑脊液中SLI存在分子异质性。第三脑室中SST - 14与SST - 28的比值高于侧脑室。

相似文献

1
Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.帕金森病中的脑室液神经肽。I. 生长抑素样免疫反应性的水平与分布
Neuropeptides. 1990 Apr;15(4):219-25. doi: 10.1016/0143-4179(90)90016-r.
2
Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease.
J Neurol. 1985;232(4):219-22. doi: 10.1007/BF00313783.
3
CSF somatostatin-like immunoreactivity in dementia.痴呆症患者脑脊液中生长抑素样免疫反应性
Neurology. 1986 Feb;36(2):294-7. doi: 10.1212/wnl.36.2.294.
4
Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.帕金森病老年及痴呆患者体内的生长抑素样免疫反应性、其分子形式及单胺能代谢产物——左旋多巴的影响
J Neural Transm (Vienna). 1996;103(5):591-602. doi: 10.1007/BF01273156.
5
Somatostatin-like immunoreactivity in cerebroventricular fluid of patients with basal midline tumours.基底中线肿瘤患者脑脊液中的生长抑素样免疫反应性
Neurol Res. 1987 Sep;9(3):205-10. doi: 10.1080/01616412.1987.11739797.
6
Molecular size distribution of somatostatin-like immunoreactivity in the cerebroventricular fluid of neurosurgical patients.神经外科患者脑脊液中生长抑素样免疫反应性的分子大小分布
Neurosci Res. 1987 Jun;4(5):343-56. doi: 10.1016/0168-0102(87)90001-0.
7
CSF cyclic nucleotides and somatostatin in Parkinson's disease.
Neurology. 1986 Jan;36(1):89-92. doi: 10.1212/wnl.36.1.89.
8
Ventricular fluid neuropeptides in Parkinson's disease. II. Levels of substance P-like immunoreactivity.帕金森病中的脑室液神经肽。II. P物质样免疫反应性水平
Neuropeptides. 1991 Feb;18(2):69-73. doi: 10.1016/0143-4179(91)90002-z.
9
Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
Neurosci Res. 1986 Feb;3(3):213-25. doi: 10.1016/0168-0102(86)90003-9.
10
Human cerebrospinal fluid somatostatin in neurologic disease.神经疾病中的人类脑脊液生长抑素
J Neurol Sci. 1985 Nov;71(1):91-104. doi: 10.1016/0022-510x(85)90039-5.

引用本文的文献

1
Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.帕金森病患者的脑脊液生化研究:寻找这种疾病潜在生物标志物的方法。
Front Cell Neurosci. 2014 Nov 11;8:369. doi: 10.3389/fncel.2014.00369. eCollection 2014.
2
Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.衰老与疾病中神经肽的改变。病理生理学及临床干预潜力。
Drugs Aging. 1993 Sep-Oct;3(5):408-27. doi: 10.2165/00002512-199303050-00003.